Abivax SA American Depositary Shares

Stock Chart, Company Information, and Scan Results

$138.72(as of Dec 22, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators

Stock Price$138.72
Ticker SymbolABVX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees67
CountyUSA
Market Cap$8,188.0M
EBIDTA-185.7M
10-Day Moving Average121.62
P/E Ratio-26.92
20-Day Moving Average120.33
Forward P/E Ratio0.00
50-Day Moving Average108.99
Earnings per Share-3.58
200-Day Moving Average52.89
Profit Margin-Infinity%
RSI66.41
Shares Outstanding77.8M
ATR8.57
52-Week High139.62
Volume4,152,022
52-Week Low4.77
Most Recent Support Level108.53
Book Value511.2M
Most Recent Resistance Level138.49
P/B Ratio21.12
Upper Keltner139.62
P/S Ratio1,146.62
Lower Keltner101.04
Debt-to-Equity Ratio139.62
Next Earnings Date03/23/2026
Cash Surplus510.9M
Next Ex-Dividend DateUnknown

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Abivax SA American Depositary Shares In Our Stock Scanner

As of Dec 23, 2025
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.